연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1621. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial.
Kang HJ, Loftus S, Taylor A, DiCristina C, Green S, Zwaan CM.
Lancet Oncol.2015 Apr;16(4):385-94.
Link
1620. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily IV busulfan fludarabine etoposide regimen in pediatric and infant ALL patients.
Lee JW, Kang HJ, Kim S, Lee S, Yu KS, Kim NH, Jang MK, Kim H, Song SH, Park JD, Park KD, Shin HY, Jang IJ, Ahn HS.
Biol Blood Marrow Transplant. 2015 Jan;21(1):190-5.
Link
1619. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
Bae JM1, Kim JH1, Rhee YY1, Cho NY1, Kim TY1, Kang GH1.
World J Gastroenterol. 2015 Sep 7;21(33):9749-57. doi: 10.3748/wjg.v21.i33.9749.
Link
1618. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH1, Cho NY2, Bae JM3, Kim KJ3, Rhee YY3, Lee HS4, Kang GH5.
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1920-8. eCollection 2015.
Link
1617. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
Kim Y1, Bae JM2, Li G1, Cho NY2, Kang GH3.
PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015.
Link
1616. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY1, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH.
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.
Link
1615. Gastric-type expression signature in serrated pathway-associated colorectal tumors.
Kim JH1, Kim KJ2, Rhee YY2, Bae JM2, Cho NY3, Lee HS4, Kang GH5.
Hum Pathol. 2015 May;46(5):643-56. doi: 10.1016/j.humpath.2015.01.003. Epub 2015 Jan 15
Link
1614. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM1, Lee TH1, Cho NY1, Kim TY1, Kang GH1.
World J Gastroenterol. 2015 Feb 7;21(5):1457-67. doi: 10.3748/wjg.v21.i5.1457.
Link
1613. Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.
Kim JH1, Kim KJ2, Bae JM2, Rhee YY2, Cho NY3, Lee HS4, Kang GH5.
J Clin Pathol. 2015 Jan;68(1):22-8. doi: 10.1136/jclinpath-2014-202603. Epub 2014 Oct 16.
Link
1612. Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer
Lee SJ, Seo HJ, Kang KW, Jeong SY, Yi NJ, Lee JM, Chung JK, Edmund Kim E, Paeng JC, Cheon GJ, Lee DS
Clin Nucl Med. 2015 Aug;40(8):e392-8
Link